Should dopamine agonist treatment for prolactinomas be life-long?
Faglia
G
G
Institute of Endocrine Sciences, University of Milan, Milano, Italy.
D015259:Dopamine Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*
D015259:Dopamine Agents